Visual Analogue Scale — Measuring Pain & Symptoms

The visual analogue scale is a psychometric response scale designed to capture internal sensations that cannot be directly measured by laboratory instruments. In its standard format, it consists of a straight horizontal or vertical line, exactly 100 millimetres in length. The ends are anchored by extreme descriptors of the symptom being assessed, such as 'no pain' on the left and 'worst pain imaginable' on the right.

The patient marks a point along the line that reflects their current discomfort. The clinician measures the distance from the negative anchor to the mark in millimetres, yielding a continuous numerical score from 0 to 100. This continuous measurement provides greater sensitivity to small symptom changes than categorical scales.

Effective symptom control relies entirely on honest and precise communication between you and your healthcare team. The visual analogue scale removes guesswork from symptom reporting, offering a consistent reference across multiple appointments. When doctors know whether your pain is mild, moderate, or severe, they can choose the right medications, adjust doses, or explore alternative supportive therapies, ensuring you maintain the best possible quality of life throughout treatment.

The visual analogue scale is an observational assessment rather than a biological test or biomarker. It is frequently evaluated alongside vital signs, functional scores, and broader quality-of-life questionnaires (such as the EORTC QLQ-C30). In research settings, VAS scores are recorded systematically to quantify how new anti-cancer or pain therapies affect patient comfort.

The visual analogue scale is not specific to any single cancer type. It is universally employed across all solid tumours and haematological malignancies, including breast, prostate, lung, colorectal, and bone cancers. It is particularly valuable in advanced or metastatic cancers, where symptom management, palliative care, and comfort-focused interventions are central goals of the treatment strategy.

Scores from a visual analogue scale directly guide supportive prescriptions. For instance, higher pain scores often prompt the initiation or titration of non-opioid or opioid analgesics according to the WHO pain ladder. Lowering scores over successive visits indicates successful symptom control, while persistently high scores may trigger changes in medication, nerve blocks, or palliative radiotherapy.